Who has invested in iOnctura?

Merck, European Innovation Council Fund, Pfizer are named among the investors backing iOnctura.

iOnctura Funding: $130M Raised, Series B (2024)

iOnctura funding overview

iOnctura is based in Geneva, Switzerland. iOnctura has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for iOnctura runs through 2024; nothing later has been disclosed. Investors on record include Merck, European Innovation Council Fund, Pfizer. 3 distinct backers are named across the disclosed rounds.

iOnctura at a glance

Total raised: $130M
Latest round: Series B
Latest round date: January 2024
Headquarters: Geneva, Switzerland
Notable investors: Merck, European Innovation Council Fund, Pfizer

Frequently asked about iOnctura funding

How much has iOnctura raised?: iOnctura has raised $130M in total disclosed funding across the rounds on record.
Who has invested in iOnctura?: Merck, European Innovation Council Fund, Pfizer are named among the investors backing iOnctura.
What was the latest iOnctura funding round?: The most recent disclosed round is a Series B, announced in January 2024.
Where is iOnctura based?: iOnctura is based in Geneva, Switzerland.
When did iOnctura last raise?: The last disclosed iOnctura round closed in January 2024 at Series B.

Totals shown for iOnctura aggregate every disclosed round on file. To see how that compares, browse the companies in Geneva and the investors behind them below.

iOnctura Funding: $130M Raised, Series B (2024)

iOnctura funding overview

iOnctura at a glance

Frequently asked about iOnctura funding

Companies related to iOnctura (18)

Browse related funding lists (6)